CIK 0001756262 · Large accelerated filer
TransMedics Group, Inc.
Sign in to watch- Ticker
- TMDX
- Exchange
- Nasdaq
- Industry
- Electromedical & Electrotherapeutic Apparatus
- FY end
- Dec 31
- Incorporated
- MA
- Entity type
- operating
- Phone
- 9785520900
- Business address
- 200 MINUTEMAN ROAD, ANDOVER, MA, 01810
- Open-market buys, last 90 days
- $109,058
- in 1 filing
- Open-market sales, last 90 days
- $385,464
- in 1 filing
Net −$276,406. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-05-29 | Weill David Director | Sale | −1,193 | $141.65 | $169K | 10,732 |
| 2024-05-29 | Gordon Stephen Chief Financial Officer | Sale | −2,000 | $141.27 | $283K | 21,299 |
| 2024-05-29 | Gordon Stephen Chief Financial Officer | Option exercise | +2,000 | $16.14 | $32K | 23,299 |
| 2024-05-29 | Gordon Stephen Chief Financial Officer | Option exercise | +5,000 | $38.46 | $192K | 28,299 |
| 2024-05-29 | Gordon Stephen Chief Financial Officer | Option exercise | +5,000 | $13.28 | $66K | 33,299 |
| 2024-05-29 | Gordon Stephen Chief Financial Officer | Option exercise | +1,000 | $83.14 | $83K | 34,299 |
| 2024-05-29 | Gordon Stephen Chief Financial Officer | Option exercise | +5,000 | $66.10 | $331K | 39,299 |
| 2024-05-29 | Gordon Stephen Chief Financial Officer | Sale | −9,345 | $141.06 | $1.3M | 29,954 |
| 2024-05-29 | Gordon Stephen Chief Financial Officer | Sale | −8,655 | $141.80 | $1.2M | 21,299 |
| 2024-05-29 | Gordon Stephen Chief Financial Officer | Option exercise · Stock Option (Right to Buy) | −2,000 | 84 | ||
| 2024-05-29 | Gordon Stephen Chief Financial Officer | Option exercise · Stock Option (Right to Buy) | −5,000 | 17,477 | ||
| 2024-05-29 | Gordon Stephen Chief Financial Officer | Option exercise · Stock Option (Right to Buy) | −5,000 | 23,167 | ||
| 2024-05-29 | Gordon Stephen Chief Financial Officer | Option exercise · Stock Option (Right to Buy) | −1,000 | 17,690 | ||
| 2024-05-29 | Gordon Stephen Chief Financial Officer | Option exercise · Stock Option (Right to Buy) | −5,000 | 15,022 | ||
| 2024-05-23 | Weill David Director | Grant or award | +732 | 11,925 | ||
| 2024-05-23 | Weill David Director | Grant or award · Stock Option (Right to Buy) | +1,154 | 1,154 | ||
| 2024-05-23 | Basile Edward M Director | Grant or award | +732 | 1,925 | ||
| 2024-05-23 | Basile Edward M Director | Grant or award · Stock Option (Right to Buy) | +1,154 | 1,154 | ||
| 2024-05-23 | Gunderson Thomas James Director | Grant or award | +732 | 1,925 | ||
| 2024-05-23 | Gunderson Thomas James Director | Grant or award · Stock Option (Right to Buy) | +1,154 | 1,154 |
Page 13 of 20 · 390 trades